{"id":"NCT04719832","sponsor":"GlaxoSmithKline","briefTitle":"Placebo-controlled Efficacy and Safety Study of GSK3511294 (Depemokimab) in Participants With Severe Asthma With an Eosinophilic Phenotype","officialTitle":"A 52-week, Randomised, Double-blind, Placebo-controlled, Parallel-group, Multi-centre Study of the Efficacy and Safety of GSK3511294 Adjunctive Therapy in Adult and Adolescent Participants With Severe Uncontrolled Asthma With an Eosinophilic Phenotype","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-03-17","primaryCompletion":"2023-11-21","completion":"2023-11-21","firstPosted":"2021-01-22","resultsPosted":"2024-12-17","lastUpdate":"2024-12-17"},"enrollment":395,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"BIOLOGICAL","name":"GSK3511294 (Depemokimab)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"GSK3511294","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a multi-center, randomized, placebo-controlled, double-blind, parallel group study that aims to assess the efficacy and safety of GSK3511294 (Depemokimab) in participants with severe uncontrolled asthma with an eosinophilic phenotype","primaryOutcome":{"measure":"Annualized Rate of Clinically Significant Exacerbations up to 52 Weeks","timeFrame":"Up to Week 52","effectByArm":[{"arm":"Placebo","deltaMin":1.11,"sd":0.86},{"arm":"GSK3511294","deltaMin":0.46,"sd":0.36}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.001"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":12},"locations":{"siteCount":123,"countries":["United States","Canada","China","Czechia","France","Germany","Ireland","Italy","Poland","Russia","Spain","United Kingdom"]},"refs":{"pmids":["39248309"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":22,"n":132},"commonTop":["COVID-19","Nasopharyngitis","Upper respiratory tract infection","Rhinitis","Headache"]}}